Drugmakers’s Bolt-On Deals Send Health-Care M&A Up 160%

Vas Narasimhan, chief executive officer of Novartis
Photographer: Stefan Wermuth/Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Ashleigh Furlong and Angela Feliciano

February 6, 2024 at 5:59 PM UTC

This article is for subscribers only.

Hi, it’s Ashleigh Furlong and Angela Feliciano in London, rounding up the recent run of health-care M&A. Elsewhere today, Byron Allen opens Paramount talks and Barclays seeks an LBO comeback.

Today's top stories